Steven J. Swanson
Keine laufenden Positionen mehr
Karriereverlauf von Steven J. Swanson
Ehemalige bekannte Positionen von Steven J. Swanson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.02.2015 | 15.10.2018 |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Ausbildung von Steven J. Swanson
| North Central College | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
- Börse
- Insiders
- Steven J. Swanson
- Erfahrung
